KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 192 filers reported holding KITE PHARMA INC in Q4 2016. The put-call ratio across all filers is 2.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $970,000 | -11.7% | 9,352 | -61.8% | 0.01% | 0.0% |
| Q4 2016 | $1,099,000 | -2.3% | 24,503 | +21.6% | 0.01% | -14.3% |
| Q3 2016 | $1,125,000 | +10.2% | 20,147 | -1.4% | 0.01% | +16.7% |
| Q2 2016 | $1,021,000 | +41.8% | 20,426 | +30.4% | 0.01% | +50.0% |
| Q1 2016 | $720,000 | -1.4% | 15,665 | +30.7% | 0.00% | 0.0% |
| Q2 2015 | $730,000 | – | 11,981 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|